Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 2
2000 1
2002 1
2003 2
2004 2
2005 4
2006 2
2007 2
2008 1
2012 1
2014 4
2015 1
2016 21
2017 18
2018 24
2019 25
2020 10
2021 10
2022 10
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW. Lee J, et al. Cancer Res Treat. 2022 Oct;54(4):1074-1080. doi: 10.4143/crt.2021.864. Epub 2021 Dec 21. Cancer Res Treat. 2022. PMID: 34942684 Free PMC article.
The presence of microcalcification and progesterone receptor expression may be potential predictors of upgradation of LCIS on preoperative biopsy. Surgical excision of the LCIS during preoperative biopsy could be a management option to identify the concealed malignancy....
The presence of microcalcification and progesterone receptor expression may be potential predictors of upgradation of LCIS on preoper …
Effective Surveillance of High-Risk Women.
Lotz M, Ghebremichael M, Chervinsky K, Zorc T, Brenner C, Bousvaros G, Pories SE. Lotz M, et al. Clin Breast Cancer. 2022 Apr;22(3):e263-e269. doi: 10.1016/j.clbc.2021.07.014. Epub 2021 Jul 27. Clin Breast Cancer. 2022. PMID: 34429241
Over the 5-year period, 60 women dropped out of the screening regimen, 6 patients were diagnosed with breast cancer on screening MRIs, and 2 additional patients were diagnosed with breast cancer on screening mammograms. Surprisingly, the highest Tyrer-Cuzick (T-C) scores d …
Over the 5-year period, 60 women dropped out of the screening regimen, 6 patients were diagnosed with breast cancer on screening MRIs, and 2 …
Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes.
Savage JL, Jeffries DO, Noroozian M, Sabel MS, Jorns JM, Helvie MA. Savage JL, et al. AJR Am J Roentgenol. 2018 Aug;211(2):462-467. doi: 10.2214/AJR.17.19088. Epub 2018 Jun 12. AJR Am J Roentgenol. 2018. PMID: 29894223
Four of 15 (27%; 95% CI, 4-49%) cases of PLCIS at CNB were upgraded to DCIS (two cases) or invasive lobular cancer (two cases) at lumpectomy (one patient declined excision). No unique mammographic features were predictive of need to upgrade or extent of disease. Among the …
Four of 15 (27%; 95% CI, 4-49%) cases of PLCIS at CNB were upgraded to DCIS (two cases) or invasive lobular cancer (two cases) at lumpectomy …
Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma.
Mouabbi JA, Raghavendra AS, Bassett RL Jr, Christgen M, Middleton L, Teshome M, Nasrazadani A, Hortobagyi G, Hassan A, Tripathy D, Layman RM. Mouabbi JA, et al. Eur J Cancer. 2023 Sep;191:113250. doi: 10.1016/j.ejca.2023.113250. Epub 2023 Jul 22. Eur J Cancer. 2023. PMID: 37573674
AIM: To determine if the outcomes of patients with ILC co-occurring with LCIS are similar to pure ILC and if the presence of LCIS is a prognostic factor for ILC. METHODS: In an observational, population-based investigation using data from the MD Anderson breast cancer pros …
AIM: To determine if the outcomes of patients with ILC co-occurring with LCIS are similar to pure ILC and if the presence of LCIS is a progn …
Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes.
Wu Q, Li J, Sun S, Zhu S, Chen C, Wu J, Liu Q, Wei W, Sun S. Wu Q, et al. Oncotarget. 2017 Jan 10;8(2):2361-2371. doi: 10.18632/oncotarget.13785. Oncotarget. 2017. PMID: 27926499 Free PMC article.
BACKGROUND & AIMS: To evaluate the clinical presentation, treatment and outcome of patients with breast carcinoma in situ (BCIS) with special emphasis on the role of the tumor subtype and local treatment in these patients. ...
BACKGROUND & AIMS: To evaluate the clinical presentation, treatment and outcome of patients with breast carcinoma in …
Clonal relationships between lobular carcinoma in situ and other breast malignancies.
Begg CB, Ostrovnaya I, Carniello JV, Sakr RA, Giri D, Towers R, Schizas M, De Brot M, Andrade VP, Mauguen A, Seshan VE, King TA. Begg CB, et al. Breast Cancer Res. 2016 Jun 23;18(1):66. doi: 10.1186/s13058-016-0727-z. Breast Cancer Res. 2016. PMID: 27334989 Free PMC article.
RESULTS: After exclusions for genotyping failure, a total of 84 lesions from 30 patients were evaluated successfully. Strong evidence of clonal relatedness was observed between an LCIS lesion and the invasive cancer for the preponderance of cases with lobular carcinoma. .. …
RESULTS: After exclusions for genotyping failure, a total of 84 lesions from 30 patients were evaluated successfully. Strong evidence of clo …
Cause-specific mortality in women with breast cancer in situ.
He W, Sofie Lindström L, Hall P, Czene K. He W, et al. Int J Cancer. 2017 Jun 1;140(11):2414-2421. doi: 10.1002/ijc.30413. Epub 2016 Sep 19. Int J Cancer. 2017. PMID: 27594272 Free article.
The 30-year cumulative incidence of breast cancer-specific mortality was 6.3%, which is considerably lower than 49.7% observed for other-cause mortality. Women diagnosed with BCIS were more likely to die from breast cancer (standardized mortality ratio [SMR], 3.85; 95% CI, …
The 30-year cumulative incidence of breast cancer-specific mortality was 6.3%, which is considerably lower than 49.7% observed for ot …
Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.
Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ. Desai AA, et al. Ann Surg Oncol. 2018 Oct;25(10):3064-3068. doi: 10.1245/s10434-018-6591-6. Epub 2018 Jun 26. Ann Surg Oncol. 2018. PMID: 29947004
Among patients with a final diagnosis of PLCIS, two ipsilateral recurrences were observed at follow-up: one invasive lobular carcinoma at 87 months and one PLCIS at 16 months postoperatively. CONCLUSION: PLCIS on CNB mandates surgical resection as 20% of patients may be up …
Among patients with a final diagnosis of PLCIS, two ipsilateral recurrences were observed at follow-up: one invasive lobular carcinom …
Longitudinal study of breast cancer risk markers.
Zarwan C, Diamond O, Lam P, Ghebremichael MS, Lotz M, Shen AH, Sharifi S, Rozhansky F, Gore TA, Pories SE. Zarwan C, et al. Breast J. 2021 Jan;27(1):48-51. doi: 10.1111/tbj.14097. Epub 2020 Oct 25. Breast J. 2021. PMID: 33099843
Long-term follow-up showed that 25 (7.8%) patients with AH and 5 patients with LCIS (5.7%) developed breast cancer over the follow-up period, a lower rate of breast cancer development than predicted by risk models....
Long-term follow-up showed that 25 (7.8%) patients with AH and 5 patients with LCIS (5.7%) developed breast cancer over the follow-up period …
121 results